Related Experiment Video
Updated: Apr 8, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Nirmatrelvir-Ritonavir (Paxlovid) in Patients with Epilepsy: A Focus on Drug-Drug Interactions
Gianmarco Marcianò1, Cristina Vocca1, Antonio Siniscalchi2
1Department of Health Science, University Magna Graecia, 88100 Catanzaro, Italy.
Introduction:
There is growing interest in identifying drug interactions between Paxlovid (nirmatrelvir/ritonavir), an antiviral drug used for the management of outpatients with mild to moderate coronavirus disease, and antiepileptic drugs.
Methods:
We searched the databases PubMed, MEDLINE, Cochrane, and EMBASE from their inception until 30 May 2025, using the keywords "Paxlovid" or "nirmatrelvir/ritonavir" or "antivirals COVID-19" and then "anticonvulsants" and finally "IDDs" and "drug interaction" in combination with Boolean logic operators.
Results:
Clinical studies have reported strong and important drug-drug interactions between nirmatrelvir/ritonavir and antiepileptic drugs. Interactions with antiepileptic drugs are bidirectional. Moderate or strong CYP3A4 inducers among antiepileptic drugs should be dose-adjusted in patients taking nirmatrelvir/ritonavir.
Conclusion:
In patients with epilepsy treated with antiepileptic drugs who also use Paxlovid (nirmatrelvir/ritonavir), therapeutic monitoring and intervention on the therapeutic concentration with dose adjustment of the antiepileptic drug is recommended.
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Pharmacokinetics: Drug–Drug Interactions
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
Drug toxicity: Drug–Drug Interaction
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...

